Bispecific Antibodies Targeting BCMA or GPRC5D Are Highly Effective in Relapsed Myeloma after CAR T-cell Therapy
Maximilian Merz,Danai Dima,Hamza Hashmi,Nausheen Ahmed,Friedrich Stoelzel,Tobias A. W. Holderried,Roland Fenk,Fabian Mueller,Natalia Tovar,Aina Oliver-Caldes,Kristin Rathje,James A. Davis,David Fandrei,Vladan Vucinic,Soraya Kharboutli, Ben-Niklas Baermann,Francis Ayuk,Uwe Platzbecker, Anca-Maria Albici, Nathalie Schub,Friederike Schmitz,Leyla Shune,Jack Khouri,Faiz Anwer,Shahzad Raza,Joseph Mcguirk,Zahra Mahmoudjafari, Kimberly Green,Cyrus Khandanpour,Marcel Teichert,Barbara Jeker,Michele Hoffmann,Nicolaus Kroeger,Bastian von Tresckow,Carlos Fernandez de Larrea,Thomas Pabst,Al-Ola Abdallah,Nico Gagelmann BLOOD CANCER JOURNAL（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper